892 related articles for article (PubMed ID: 9634238)
41. CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540.
Vinante F; Rigo A; Scupoli MT; Pizzolo G
Blood; 2002 Jan; 99(1):52-60. PubMed ID: 11756152
[TBL] [Abstract][Full Text] [Related]
42. [CXCR4, a therapeutic target in rare immunodeficiencies?].
Bignon A; Biajoux V; Bouchet-Delbos L; Emilie D; Lortholary O; Balabanian K
Med Sci (Paris); 2011 Apr; 27(4):391-7. PubMed ID: 21524404
[TBL] [Abstract][Full Text] [Related]
43. A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor.
Knaut H; Werz C; Geisler R; Nüsslein-Volhard C;
Nature; 2003 Jan; 421(6920):279-82. PubMed ID: 12508118
[TBL] [Abstract][Full Text] [Related]
44. [A chemokine PBSF/SDF-1 and its receptor CXCR4: function and involvement in HIV-1 infection].
Nagasawa T
Seikagaku; 1997 Dec; 69(12):1373-8. PubMed ID: 9483982
[No Abstract] [Full Text] [Related]
45. A case of WHIM syndrome associated with diabetes and hypothyroidism.
Takaya J; Fujii Y; Higashino H; Taniuchi S; Nakamura M; Kaneko K
Pediatr Diabetes; 2009 Nov; 10(7):484-6. PubMed ID: 19476565
[TBL] [Abstract][Full Text] [Related]
46. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.
Ma Q; Jones D; Springer TA
Immunity; 1999 Apr; 10(4):463-71. PubMed ID: 10229189
[TBL] [Abstract][Full Text] [Related]
47. Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons.
Zhu Y; Yu T; Zhang XC; Nagasawa T; Wu JY; Rao Y
Nat Neurosci; 2002 Aug; 5(8):719-20. PubMed ID: 12080344
[TBL] [Abstract][Full Text] [Related]
48. HIV-1, chemokines and neurogenesis.
Tran PB; Miller RJ
Neurotox Res; 2005 Oct; 8(1-2):149-58. PubMed ID: 16260392
[TBL] [Abstract][Full Text] [Related]
49. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
[TBL] [Abstract][Full Text] [Related]
50. Ectopic cerebellar cell migration causes maldevelopment of Purkinje cells and abnormal motor behaviour in Cxcr4 null mice.
Huang GJ; Edwards A; Tsai CY; Lee YS; Peng L; Era T; Hirabayashi Y; Tsai CY; Nishikawa S; Iwakura Y; Chen SJ; Flint J
PLoS One; 2014; 9(2):e86471. PubMed ID: 24516532
[TBL] [Abstract][Full Text] [Related]
51. CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems.
Guyon A
Front Cell Neurosci; 2014; 8():65. PubMed ID: 24639628
[TBL] [Abstract][Full Text] [Related]
52. Neural progenitors and HIV-1-associated central nervous system disease in adults and children.
Schwartz L; Major EO
Curr HIV Res; 2006 Jul; 4(3):319-27. PubMed ID: 16842084
[TBL] [Abstract][Full Text] [Related]
53. Foxc1 dependent mesenchymal signalling drives embryonic cerebellar growth.
Haldipur P; Gillies GS; Janson OK; Chizhikov VV; Mithal DS; Miller RJ; Millen KJ
Elife; 2014 Dec; 3():. PubMed ID: 25513817
[TBL] [Abstract][Full Text] [Related]
54. A syndrome involving intrauterine growth retardation, microcephaly, cerebellar hypoplasia, B lymphocyte deficiency, and progressive pancytopenia.
Revy P; Busslinger M; Tashiro K; Arenzana F; Pillet P; Fischer A; Durandy A
Pediatrics; 2000 Mar; 105(3):E39. PubMed ID: 10699141
[TBL] [Abstract][Full Text] [Related]
55. CXCR4: chemokine receptor extraordinaire.
Murdoch C
Immunol Rev; 2000 Oct; 177():175-84. PubMed ID: 11138774
[TBL] [Abstract][Full Text] [Related]
56. Increased stereotypy in conditional Cxcr4 knockout mice.
Cash-Padgett T; Sawa A; Jaaro-Peled H
Neurosci Res; 2016 Apr; 105():75-9. PubMed ID: 26458529
[TBL] [Abstract][Full Text] [Related]
57. Embryonic expression of the mRNA for the rat homologue of the fusin/CXCR-4 HIV-1 co-receptor.
Jazin EE; Söderström S; Ebendal T; Larhammar D
J Neuroimmunol; 1997 Nov; 79(2):148-54. PubMed ID: 9394787
[TBL] [Abstract][Full Text] [Related]
58. A future perspective on the development of chemokine receptor CXCR4 antagonists.
Tamamura H; Tsutsumi H; Nomura W; Tanaka T; Fujii N
Expert Opin Drug Discov; 2008 Oct; 3(10):1155-66. PubMed ID: 23489074
[TBL] [Abstract][Full Text] [Related]
59. On development and clinical aspects of human supratentorial bridge veins.
Kedzia A; Kedzia W
Folia Morphol (Warsz); 1996; 55(4):327-9. PubMed ID: 9243896
[No Abstract] [Full Text] [Related]
60. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.
Ma Q; Jones D; Borghesani PR; Segal RA; Nagasawa T; Kishimoto T; Bronson RT; Springer TA
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9448-53. PubMed ID: 9689100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
